Influences of alternate therapy protocol and continuous infectious disease consultation on antibiotic susceptibility in ICU

dc.contributor.buuauthorAkalın, Halis
dc.contributor.buuauthorKahveci, Ferda Şöhret
dc.contributor.buuauthorÖzakın, Cüneyt
dc.contributor.buuauthorHelvacı, Safiye
dc.contributor.buuauthorGedikoğlu, Suna
dc.contributor.buuauthorKutlay, Oya
dc.contributor.buuauthorTöre, Okan
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji ve Enfeksiyon Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Anesteziyoloji ve Reanimasyon Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0003-4820-2288tr_TR
dc.contributor.scopusid57207553671tr_TR
dc.contributor.scopusid6602405968tr_TR
dc.contributor.scopusid57200678942tr_TR
dc.contributor.scopusid6602103491tr_TR
dc.contributor.scopusid6603407548tr_TR
dc.contributor.scopusid6602199747tr_TR
dc.contributor.scopusid6505909596tr_TR
dc.date.accessioned2021-11-18T07:51:55Z
dc.date.available2021-11-18T07:51:55Z
dc.date.issued1999
dc.description.abstractIn this study, the effects of alternate use of imipenem and cef-operazone/sulbactam(CFP/Sul) on antibiotic resistance in the intensive care unit (ICU) were investigated, Between 1 April 1993 and 1 April 1994, the infectious diseases consultant saw patients when required and there was no alternative therapy for antibiotics. For the following 2 years, the same consultant followed up each patient from admission to discharge by daily visits to the ICU and an alternative therapy protocol was initiated, The most common microorganisms were found to be Acinetobacter baumannii and Staphylococcus aureus, followed by Pseudomonas aeruginosa and Klebsiella pneumoniae, respectively, in the two periods. This study demonstrated that sensitivity rates of imipenem, ciprofloxacin and aminoglycosides were improved as a result of this protocol.en_US
dc.identifier.citationAkalın, H. vd. (1999). "Influences of alternate therapy protocol and continuous infectious disease consultation on antibiotic susceptibility in ICU". Intensive Care Medicine, 25(9), 1010-1012.en_US
dc.identifier.endpage1012tr_TR
dc.identifier.issn0342-4642
dc.identifier.issue9tr_TR
dc.identifier.pubmed10501761tr_TR
dc.identifier.scopus2-s2.0-0032822872tr_TR
dc.identifier.startpage1010tr_TR
dc.identifier.urihttps://doi.org/10.1007/s001340050998
dc.identifier.urihttps://link.springer.com/article/10.1007%2Fs001340050998
dc.identifier.urihttp://hdl.handle.net/11452/22713
dc.identifier.volume25tr_TR
dc.identifier.wos000082918200026tr_TR
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.journalIntensive Care Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGeneral & internal medicineen_US
dc.subjectAlternate use of antibioticsen_US
dc.subjectResistanceen_US
dc.subject.emtreeAmikacinen_US
dc.subject.emtreeAminoglycosideen_US
dc.subject.emtreeCefoperazoneen_US
dc.subject.emtreeCeftazidimeen_US
dc.subject.emtreeCeftriaxoneen_US
dc.subject.emtreeCiprofloxacinen_US
dc.subject.emtreeGentamicinen_US
dc.subject.emtreeImipenemen_US
dc.subject.emtreeSulbactamen_US
dc.subject.emtreeAcinetobacter baumanniien_US
dc.subject.emtreeAntibiotic sensitivityen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeClinical protocolen_US
dc.subject.emtreeDrug choiceen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeInfection controlen_US
dc.subject.emtreeIntensive care uniten_US
dc.subject.emtreeKlebsiella pneumoniaeen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreePseudomonas aeruginosaen_US
dc.subject.emtreeStaphylococcus aureusen_US
dc.subject.meshAnti-bacterial agentsen_US
dc.subject.meshBacteriaen_US
dc.subject.meshBacterial infectionsen_US
dc.subject.meshChi-square distributionen_US
dc.subject.meshClinical protocolsen_US
dc.subject.meshCross infectionen_US
dc.subject.meshHumansen_US
dc.subject.meshIntensive careen_US
dc.subject.meshMicrobial sensitivity testsen_US
dc.subject.meshReferral and consultationen_US
dc.subject.meshTime factorsen_US
dc.subject.scopusAntimicrobial Stewardship; Carbapenems; Inappropriate Prescribingen_US
dc.subject.wosCritical care medicineen_US
dc.titleInfluences of alternate therapy protocol and continuous infectious disease consultation on antibiotic susceptibility in ICUen_US
dc.typeArticle

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: